Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7609 | 1348 | 32.9 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
110 | 3 | PSYCHIATRY//SCHIZOPHRENIA//BIPOLAR DISORDER | 71389 |
617 | 2 | ANTIPSYCHOTICS//CLOZAPINE//SCHIZOPHRENIA | 13940 |
7609 | 1 | 9 HYDROXYRISPERIDONE//NORCLOZAPINE//CLOZAPINE | 1348 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | 9 HYDROXYRISPERIDONE | authKW | 1264934 | 5% | 85% | 66 |
2 | NORCLOZAPINE | authKW | 656870 | 2% | 100% | 29 |
3 | CLOZAPINE | authKW | 638229 | 20% | 10% | 273 |
4 | PALIPERIDONE | authKW | 578247 | 4% | 43% | 60 |
5 | RISPERIDONE | authKW | 469226 | 15% | 11% | 197 |
6 | OLANZAPINE | authKW | 375812 | 13% | 9% | 178 |
7 | CLOZAPINE N OXIDE | authKW | 349463 | 1% | 86% | 18 |
8 | QUETIAPINE | authKW | 225711 | 7% | 10% | 95 |
9 | DESMETHYLCLOZAPINE | authKW | 205914 | 1% | 91% | 10 |
10 | N DESMETHYLCLOZAPINE | authKW | 167828 | 1% | 44% | 17 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 12256 | 55% | 0% | 745 |
2 | Psychiatry | 11657 | 34% | 0% | 455 |
3 | Chemistry, Analytical | 2218 | 18% | 0% | 248 |
4 | Medical Laboratory Technology | 2194 | 7% | 0% | 93 |
5 | Toxicology | 1367 | 10% | 0% | 137 |
6 | Biochemical Research Methods | 821 | 9% | 0% | 122 |
7 | Clinical Neurology | 635 | 11% | 0% | 146 |
8 | Neurosciences | 317 | 11% | 0% | 153 |
9 | Medicine, Legal | 179 | 1% | 0% | 18 |
10 | Emergency Medicine | 128 | 1% | 0% | 20 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | POLICLIN UNIV MESSINA | 94376 | 0% | 83% | 5 |
2 | EASTERN STATE HOSP | 67034 | 1% | 20% | 15 |
3 | BLACKTOWN MENTAL HLTH SERV | 45301 | 0% | 100% | 2 |
4 | COURSE BASIC CLIN SCI | 45301 | 0% | 100% | 2 |
5 | MEMS SENSORS ACTUATORS MSAL | 30196 | 0% | 33% | 4 |
6 | TDM TOXICOL | 25881 | 0% | 29% | 4 |
7 | DRUG DISPOSIT PHARMACOGENET | 24652 | 1% | 16% | 7 |
8 | ADV PSYCHOPHARMACOL EVALUAT | 22651 | 0% | 100% | 1 |
9 | AFD BIOL PSYKIATRI | 22651 | 0% | 100% | 1 |
10 | AFFILIATED BEIJING AN DING HOSP | 22651 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THERAPEUTIC DRUG MONITORING | 41728 | 6% | 2% | 83 |
2 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 19234 | 4% | 2% | 48 |
3 | PHARMACOPSYCHIATRY | 14600 | 3% | 2% | 36 |
4 | PSYCHOPHARMAKOTHERAPIE | 13138 | 1% | 3% | 17 |
5 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 7070 | 2% | 1% | 24 |
6 | HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL | 6379 | 2% | 1% | 22 |
7 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 4108 | 3% | 0% | 47 |
8 | JOURNAL OF PSYCHOPHARMACOLOGY | 3178 | 1% | 1% | 18 |
9 | CLINICAL NEUROPHARMACOLOGY | 2706 | 1% | 1% | 17 |
10 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 2484 | 3% | 0% | 35 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | 9 HYDROXYRISPERIDONE | 1264934 | 5% | 85% | 66 | Search 9+HYDROXYRISPERIDONE | Search 9+HYDROXYRISPERIDONE |
2 | NORCLOZAPINE | 656870 | 2% | 100% | 29 | Search NORCLOZAPINE | Search NORCLOZAPINE |
3 | CLOZAPINE | 638229 | 20% | 10% | 273 | Search CLOZAPINE | Search CLOZAPINE |
4 | PALIPERIDONE | 578247 | 4% | 43% | 60 | Search PALIPERIDONE | Search PALIPERIDONE |
5 | RISPERIDONE | 469226 | 15% | 11% | 197 | Search RISPERIDONE | Search RISPERIDONE |
6 | OLANZAPINE | 375812 | 13% | 9% | 178 | Search OLANZAPINE | Search OLANZAPINE |
7 | CLOZAPINE N OXIDE | 349463 | 1% | 86% | 18 | Search CLOZAPINE+N+OXIDE | Search CLOZAPINE+N+OXIDE |
8 | QUETIAPINE | 225711 | 7% | 10% | 95 | Search QUETIAPINE | Search QUETIAPINE |
9 | DESMETHYLCLOZAPINE | 205914 | 1% | 91% | 10 | Search DESMETHYLCLOZAPINE | Search DESMETHYLCLOZAPINE |
10 | N DESMETHYLCLOZAPINE | 167828 | 1% | 44% | 17 | Search N+DESMETHYLCLOZAPINE | Search N+DESMETHYLCLOZAPINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RAGGI, MA , MANDRIOLI, R , SABBIONI, C , PUCCI, V , (2004) ATYPICAL ANTIPSYCHOTICS: PHARMACOKINETICS, THERAPEUTIC DRUG MONITORING AND PHARMACOLOGICAL INTERACTIONS.CURRENT MEDICINAL CHEMISTRY. VOL. 11. ISSUE 3. P. 279-296 | 139 | 62% | 66 |
2 | SPINA, E , DE LEON, J , (2007) METABOLIC DRUG INTERACTIONS WITH NEWER ANTIPSYCHOTICS: A COMPARATIVE REVIEW.BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. VOL. 100. ISSUE 1. P. 4 -22 | 94 | 63% | 115 |
3 | KENNEDY, WK , JANN, MW , KUTSCHER, EC , (2013) CLINICALLY SIGNIFICANT DRUG INTERACTIONS WITH ATYPICAL ANTIPSYCHOTICS.CNS DRUGS. VOL. 27. ISSUE 12. P. 1021-1048 | 77 | 66% | 15 |
4 | SPINA, E , HIEMKE, C , DE LEON, J , (2016) ASSESSING DRUG-DRUG INTERACTIONS THROUGH THERAPEUTIC DRUG MONITORING WHEN ADMINISTERING ORAL SECOND-GENERATION ANTIPSYCHOTICS.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 12. ISSUE 4. P. 407 -422 | 64 | 74% | 0 |
5 | URICHUK, L , PRIOR, TI , DURSUN, S , BAKER, G , (2008) METABOLISM OF ATYPICAL ANTIPSYCHOTICS: INVOLVEMENT OF CYTOCHROME P450 ENZYMES AND RELEVANCE FOR DRUG-DRUG INTERACTIONS.CURRENT DRUG METABOLISM. VOL. 9. ISSUE 5. P. 410 -418 | 67 | 66% | 74 |
6 | REMINGTON, G , AGID, O , FOUSSIAS, G , FERGUSON, L , MCDONALD, K , POWELL, V , (2013) CLOZAPINE AND THERAPEUTIC DRUG MONITORING: IS THERE SUFFICIENT EVIDENCE FOR AN UPPER THRESHOLD?.PSYCHOPHARMACOLOGY. VOL. 225. ISSUE 3. P. 505-518 | 58 | 71% | 17 |
7 | CHETTY, M , MURRAY, M , (2007) CYP-MEDIATED CLOZAPINE INTERACTIONS: HOW PREDICTABLE ARE THEY?.CURRENT DRUG METABOLISM. VOL. 8. ISSUE 4. P. 307-313 | 76 | 57% | 24 |
8 | CHUE, PS , MACKENZIE, EM , CHUE, JA , BAKER, GB , (2012) THE PHARMACOLOGY AND FORMULATION OF PALIPERIDONE EXTENDED RELEASE.EXPERT REVIEW OF NEUROTHERAPEUTICS. VOL. 12. ISSUE 12. P. 1399-1410 | 55 | 69% | 7 |
9 | RAGGI, MA , (2002) THERAPEUTIC DRUG MONITORING: CHEMICAL-CLINICAL CORRELATIONS OF ATYPICAL ANTIPSYCHOTIC DRUGS.CURRENT MEDICINAL CHEMISTRY. VOL. 9. ISSUE 14. P. 1397 -1409 | 70 | 65% | 30 |
10 | MAURI, MC , VOLONTERI, LS , COLASANTI, A , FIORENTINI, A , DE GASPARI, IF , BAREGGI, SR , (2007) CLINICAL PHARMACOKINETICS OF ATYPICAL ANTIPSYCHOTICS - A CRITICAL REVIEW OF THE RELATIONSHIP BETWEEN PLASMA CONCENTRATIONS AND CLINICAL RESPONSE.CLINICAL PHARMACOKINETICS. VOL. 46. ISSUE 5. P. 359-388 | 67 | 47% | 137 |
Classes with closest relation at Level 1 |